Does vitamin B12 before pregnancy lower birth defects?
In this study, yes. Among 3,032 couples who gave blood in the four months before conception, pregnancies in the lowest maternal vitamin B12 group had about 49.6 birth defects per 1,000, compared with 16.2 per 1,000 in the highest group.
That gap is about 33 fewer birth defects per 1,000 pregnancies, or roughly one fewer for every 30 pregnancies. In relative terms it works out to about 67% lower. This was an observational study, so it shows which blood levels travel with fewer defects, not that swallowing a supplement produces that result. Even so, the pattern was a stair-step: as vitamin B12 went up, the predicted rate of birth defects came down.
Folic acid gets nearly all the attention in pregnancy nutrition, and for good reason, since maternal folic acid prevents neural tube defects. Vitamin B12 is the other half of the same chemistry. The two vitamins work together in the reaction that supplies methyl groups for building and reading DNA, which is exactly the machinery an embryo runs hardest in the first weeks. This study measured both, in both parents, and the B12 signal was the stronger one.
What the data show
The Shanghai Preconception Cohort measured red blood cell folate and vitamin B12 in two overlapping groups. One was 3,032 couples with blood sampled within four months before conception, which produced 73 birth defect cases. The other was 17,765 women with blood sampled at four months of pregnancy or earlier, which produced 327 cases. Birth defects were counted across live births, stillbirths, and abortions due to fetal abnormalities, so pregnancies that ended early because a serious defect was found still counted. Studies that look only at surviving babies miss the most severe cases, and this one did not.
The father’s blood told a similar story. Comparing the lowest paternal vitamin B12 group with the highest, predicted birth defects fell from 55.5 to 24.0 per 1,000 pregnancies. That is about 31 fewer per 1,000, roughly one fewer for every 32 pregnancies, or about 57% lower in relative terms. The authors describe the paternal pattern as similar to the maternal one but weaker.
Folate behaved differently depending on timing. Before conception, red blood cell folate showed what the authors call imprecise patterns, meaning the numbers leaned toward fewer defects but were too unsteady to lean on. After conception, folate mattered more clearly. Women with red blood cell folate between 906 and 1,131 nmol/L had 16.5 birth defects per 1,000 pregnancies, compared with 25.7 per 1,000 in women below 453 nmol/L. That is about 9 fewer per 1,000, roughly one fewer for every 109 pregnancies, and about 36% lower. Above that band, the authors report little further reduction. Vitamin B12 after conception followed its own shape, changing little across the lower categories but landing lower at the top: 11.8 per 1,000 at 590 pmol/L or above, versus 20.4 per 1,000 in the 148 to 294 pmol/L range.
Dr. Kumar’s Take
The folate ceiling is the most useful thing in this paper. Public health messaging about folic acid has trained people to think of it as a more-is-better nutrient, and this data does not support that. The drop happened between the bottom category and the 906 to 1,131 nmol/L band, and then it flattened. Getting out of deficiency is where the benefit lives. Pushing past a sufficient level did not buy anything measurable here.
The second point is that vitamin B12 is not treated with the same seriousness as folate in preconception care, and this study argues it should be. B12 status is the one people are most likely to be short on without knowing, particularly on vegetarian and vegan diets, after weight loss surgery, on long-term metformin, or with low stomach acid.
The paternal finding deserves attention without getting ahead of the evidence. A father’s blood nutrient level does not travel to the fetus, so the mechanism would have to run through sperm, either through DNA methylation patterns carried in sperm or through some shared household diet that both parents eat. This study cannot separate those two explanations, and the second one is the boring answer that fits the data just as well.
Why “more is better” fails here
The shape of the curve is the finding, not just the endpoints. When a nutrient prevents a problem by correcting a shortage, the graph looks like this one: steep improvement out of the deficient range, then flat. That is a threshold, not a dose that keeps paying. It is the same reason topping off a nutrient you already have enough of does not usually help, and it applies to most vitamins rather than just this one.
There is a practical consequence. High folate intake can mask a vitamin B12 deficiency by correcting the blood count changes while the nerve damage continues underneath. In a population where folic acid supplementation is routine and B12 is not checked, that combination is worth knowing about, and this study’s B12 findings make it more relevant, not less.
Limits worth knowing
The authors name residual confounding as their limitation, which is the honest one. People with higher vitamin B12 tend to eat differently, earn differently, and get prenatal care differently, and statistical adjustment never fully removes that. This was a single cohort in Shanghai, so diet patterns and background supplement use may not match other populations. The preconception analysis rested on 73 birth defect cases, a small number of events to carry a dose-response curve. And the figures reported are standardized predicted prevalences from a statistical model rather than raw counts, which means they describe what the model expects at each nutrient level.
Practical Takeaways
- If you are planning a pregnancy, ask about testing vitamin B12 alongside the usual folate advice, since B12 status is easy to check and easy to miss.
- Vegetarians, vegans, people on long-term metformin, and anyone who has had weight loss surgery are the groups most likely to run low on B12, and they are the ones this study speaks to most directly.
- Do not read this as a reason to megadose folic acid, since the benefit in this cohort flattened out above the 906 to 1,131 nmol/L range rather than continuing to climb.
- The window that mattered here was before conception and the first four months, so nutrition changes made after a positive pregnancy test are already partly late.
Related Studies and Research
- A father’s health before conception shapes his children’s future
- Vitamin B12 from animal foods: why stomach acid matters
- Low B12 and folate are linked to fatigue
- Even “normal” vitamin B12 may not protect your aging brain
- Everyday chemicals in pregnancy linked to early birth
FAQs
How do I find out if my vitamin B12 is low before pregnancy?
A serum vitamin B12 level is a routine, inexpensive blood test, and it is the usual starting point. The complication is that a result in the low-normal range can still leave the body short at the cellular level, which is why a methylmalonic acid or homocysteine level is sometimes added when the picture is unclear. Deficiency also builds slowly and can be silent for a long time before symptoms appear, so a normal energy level is not reassurance. If you fall into one of the higher risk groups, raising the question with your clinician before conception rather than during pregnancy gives more time to correct it.
Does the father need to take a prenatal vitamin?
This study found that paternal vitamin B12 before conception tracked with fewer birth defects, but it was an observational finding, and no trial has tested supplementing fathers to see whether outcomes change. Couples also tend to eat the same food, so a father’s blood level partly reports the household diet rather than something unique to him. What the data does support is that the father’s nutritional status is not irrelevant, which is a shift from how preconception care is usually framed. Sperm are produced continuously over roughly three months, so the months before conception are the biologically plausible window if paternal nutrition matters at all.
Can you get too much folic acid?
The concern is not toxicity in the usual sense, since excess folate is water soluble and largely excreted. The real issue is that high folate intake can normalize the blood count changes caused by vitamin B12 deficiency while nerve damage from that deficiency keeps progressing unnoticed. This study adds a separate reason to avoid chasing higher numbers: the reduction in birth defects flattened once red blood cell folate reached the 906 to 1,131 nmol/L range, so more did not translate into better. Standard prenatal doses are well within the range where the benefit was seen, and going far beyond them was not rewarded in this data.
Bottom Line
In a Shanghai cohort of 3,032 couples sampled before conception and 17,765 women sampled early in pregnancy, higher parental vitamin B12 tracked with substantially fewer birth defects. Pregnancies in the lowest maternal B12 category had 49.6 defects per 1,000 versus 16.2 per 1,000 in the highest, with a similar but weaker pattern for fathers. Folate after conception mattered too, with 16.5 defects per 1,000 in the 906 to 1,131 nmol/L range versus 25.7 per 1,000 below 453 nmol/L, and no meaningful gain above that. The message is not to take more of everything. It is that vitamin B12 belongs in the preconception conversation next to folic acid, and that with folate, getting out of the deficient range is the part that counts.
